Bionyra Pharma
Developing next-generation biologics for severe immunological and inflammatory diseases
$165MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Developing next-generation biologics for severe immunological and inflammatory diseases
Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers
Pitching Arkin Bio Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room